Human Anti-IL17RA scFv-Fc Chimera (VS-0425-FY41)

CAT#: VS-0425-FY41

The anti-IL17RA scFv-Fc is a novel therapeutic antibody designed to target the interleukin-17 receptor A (IL17RA), a key mediator in inflammatory responses. By binding specifically to IL17RA, this recombinant single-chain variable fragment fused with an IgG Fc domain helps to inhibit IL-17 signaling, which is implicated in various autoimmune conditions. The product is engineered for enhanced stability and longer half-life in circulation, making it a promising candidate for chronic disease treatment. Preclinical studies have demonstrated its potential to reduce inflammation and tissue damage in models of diseases such as psoriasis and rheumatoid arthritis. Additionally, its dual mechanism of action not only blocks IL-17 signaling but also modulates immune responses. The anti-IL17RA scFv-Fc represents a significant advancement in targeted therapies for inflammatory diseases.

Gene Expression
Figure 1 IF staining of human cell line U-251 MG Figure 2 Colon Figure 3 Liver Figure 4 RNA cell line category: Cell line enhanced (HL-60, NB-4, THP-1)

Specifications

  • Host Species
  • Human
  • Type
  • Human IgG2, scFv-Fc
  • Specificity
  • Human IL17RA
  • Species Reactivity
  • Human
  • Applications
  • Western Blot, ELISA, Dot Blot
  • Related Disease
  • Asthma, Psoriasis, Crohn's Disease, Psoriatic Arthritis, and Rheumatoid Arthritis

Product Property

  • Purity
  • >95% as determined by SDS-PAGE
  • Concentration
  • Please refer to the vial label for the specific concentration.
  • Storage
  • Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
  • Shipping
  • Ice packs

Applications

  • Application Notes
  • Western Blot: 2 μg/mL
    Dot Blot: 2 μg/mL
    The optimal dilution concentration is determined by the experiment.

Target

  • Alternative Names
  • Interleukin 17 Receptor A
  • Long Name
  • Interleukin 17 Receptor A
  • Cellular Localization
  • Cell membrane, Secreted
  • Post Translation Modifications
  • Glycosylated.
    Glycosylation at Asn49, Asn54, Asn67, Asn206, Asn225, Asn242, and Asn265
    Modification sites at PhosphoSitePlus
    Glycosylation from GlyGen 8 sites, 10 N-linked glycans (4 sites), 1 O-linked glycan (1 site)
  • Function
  • Receptor for IL17A and IL17F, major effector cytokines of innate and adaptive immune system involved in antimicrobial host defense and maintenance of tissue integrity.
    Receptor for IL17A.
    Receptor for IL17F.
    Binds to IL17A with higher affinity than to IL17F.
    Binds IL17A and IL17F homodimers as part of a heterodimeric complex with IL17RC.
    Also binds heterodimers formed by IL17A and IL17F as part of a heterodimeric complex with IL17RC.
    Cytokine binding triggers homotypic interaction of IL17RA and IL17RC chains with TRAF3IP2 adapter, leading to TRAF6-mediated activation of NF-kappa-B and MAPkinase pathways, ultimately resulting in transcriptional activation of cytokines, chemokines, antimicrobial peptides and matrix metalloproteinases, with potential strong immune inflammation.
    Involved in antimicrobial host defense primarily promoting neutrophil activation and recruitment at infection sites to destroy extracellular bacteria and fungi.
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for VS-0425-FY41. Click the button above to contact us or submit your feedback about this product.

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:

See other products for "IL17RA"

Select a product category from the dropdown menu below to view related products.

CAT Product Name Application Type
NABL-093 Recombinant Anti-human IL17RA VHH Single Domain Antibody WB, ELISA, IHC, FC, FuncS Llama VHH
CAT Product Name Application Type
TAB-134 Human Anti-IL17RA Recombinant Antibody (TAB-134) Neut, ELISA, IF, IP, FuncS, FC, ICC Human IgG2, κ
CAT Product Name Application Type
TAB-217 Anti-Human IL17RA Recombinant Antibody (TAB-217) WB, ELISA, FC, IP, FuncS, IF, Neut IgG4 - kappa
CAT Product Name Application Type
MOR-1794 Rabbit Anti-IL17RA Recombinant Antibody (clone DS1794AB) WB, IP, FC Rabbit IgG
CAT Product Name Application Type
AFC-TAB-134 Afuco™ Anti-IL17RA Recombinant Antibody (AFC-TAB-134), ADCC Enhanced Neut, ELISA, IF, IP, FuncS, FC Human IgG1, κ
AFC-TAB-217 Afuco™ Anti-IL17RA ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-217) ELISA, FC, IP, FuncS, IF ADCC enhanced antibody
CAT Product Name Application Type
VS-0425-YC580 Recombinant Anti-IL17RA Vesicular Antibody, EV Displayed (VS-0425-YC580) ELISA, FC, Neut, Cell-uptake
CAT Product Name Application Type
VS-0525-XY3496 Anti-IL17RA Immunohistochemistry Kit IHC
Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare